These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 3471918)

  • 21. The issue of quality of life in antihypertensive therapy.
    Jern S; Zanchetti A
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S46-9. PubMed ID: 8487250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha1-blockers with additional antihypertensive mechanisms. Satellite symposium of the 12th scientific meeting of the International Society of Hypertension. 28 May 1988, Kyoto, Japan.
    J Hypertens Suppl; 1988 Dec; 6(2):S1-73. PubMed ID: 2906694
    [No Abstract]   [Full Text] [Related]  

  • 23. [Arterial hypertension and quality of life: role of life quality assessment in clinical studies and practical medical activities].
    Kolpakova EV
    Ter Arkh; 2000; 72(4):71-4. PubMed ID: 10833806
    [No Abstract]   [Full Text] [Related]  

  • 24. Does antihypertensive therapy influence quality of life?
    McCorvey E; Wright JT; McKenney JM; Proctor JD
    Clin Pharm; 1989 May; 8(5):359-64. PubMed ID: 2663326
    [No Abstract]   [Full Text] [Related]  

  • 25. What is the goal of antihypertensive treatment in very elderly people?
    Rakugi H
    Hypertens Res; 2008 Jul; 31(7):1277-8. PubMed ID: 18957795
    [No Abstract]   [Full Text] [Related]  

  • 26. Round table 2. First-line drugs: the position of the World Health Organization-International Society of Hypertension.
    Chalmers J
    J Hypertens Suppl; 1993 Dec; 11(5):S381-3. PubMed ID: 8158430
    [No Abstract]   [Full Text] [Related]  

  • 27. Antihypertensive strategy using angiotensin converting inhibitors. Official satellite symposium to the 12th scientific meeting of the International Society of Hypertension. Kyoto, Japan, May 27, 1988.
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S1-80. PubMed ID: 2474094
    [No Abstract]   [Full Text] [Related]  

  • 28. Behavioral consequences of hypertension and antihypertensive therapy.
    Shapiro AP; Alderman MH; Clarkson TB; Furberg CD; Jesse MJ; Julius S; Miller RE; Pitt B
    Circulation; 1987 Jul; 76(1 Pt 2):I101-3. PubMed ID: 3594780
    [No Abstract]   [Full Text] [Related]  

  • 29. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension.
    Ogilvie RI; Burgess ED; Cusson JR; Feldman RD; Leiter LA; Myers MG
    CMAJ; 1993 Sep; 149(5):575-84. PubMed ID: 8364814
    [No Abstract]   [Full Text] [Related]  

  • 30. The impact of antihypertensive drug therapy on quality of life.
    Scherger JE
    Postgrad Med; 2000 Oct; 108(5 Suppl):25-9. PubMed ID: 19667538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Quality of live in patients with hypertension].
    Andreeva GF; Oganov RG
    Ter Arkh; 2002; 74(1):8-16. PubMed ID: 11878071
    [No Abstract]   [Full Text] [Related]  

  • 32. Symposium on compliance-improving strategies in hypertension. Satellite symposium to the 10th scientific meeting of the International Society of Hypertension. 15-16 June 1984, Flims, Switzerland.
    J Hypertens Suppl; 1985 Apr; 3(1):1-101. PubMed ID: 3870477
    [No Abstract]   [Full Text] [Related]  

  • 33. Interpreting quality-of-life clinical trial data for use in the clinical practice of antihypertensive therapy.
    Testa MA
    J Hypertens Suppl; 1987 Feb; 5(1):S9-13. PubMed ID: 3553497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of hypertension and quality of life.
    Robertson JI
    J Hypertens Suppl; 1985 Nov; 3(2):S89-90. PubMed ID: 3910777
    [No Abstract]   [Full Text] [Related]  

  • 35. [The effect of long-term monotherapy with preparations from the 4 basic groups of antihypertensive agents on the quality of life in patients with mild and moderate arterial hypertension. The Multicenter Captopril and the Quality of Life Study. The working group of the Multicenter Captopril and the Quality of Life Study].
    Metelitsa VI; Duda SG; Ostrovskaia TP; Filatova NP; Mukhamedzhanova GF; Vygodin VA; Siegrist J; Broer M
    Ter Arkh; 1995; 67(9):45-50. PubMed ID: 7495042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life before and during antihypertensive treatment: a comparative study of celiprolol and atenolol.
    Cleophas TJ; van der Mey N; van der Meulen J; Niemeyer MG
    Int J Clin Pharmacol Ther; 1996 Jul; 34(7):312-7. PubMed ID: 8832309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of treatment on health-related quality of life in patients with hypertension and renal artery stenosis.
    Krijnen P; van Jaarsveld BC; Hunink MG; Habbema JD
    J Hum Hypertens; 2005 Jun; 19(6):467-70. PubMed ID: 15759023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive therapy and quality of life.
    Rakel RE
    Am Fam Physician; 1987 Mar; 35(3):221-6. PubMed ID: 3548293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings of the Second International Symposium on Hypertension in Children and Adolescents. Heidelberg, Federal Republic of Germany, October 11-12, 1985.
    Clin Exp Hypertens A; 1986; 8(4-5):475-918. PubMed ID: 3757272
    [No Abstract]   [Full Text] [Related]  

  • 40. [Quality of life under antihypertensive therapy: essentially for compliance].
    Wenzel U; Krebs C
    MMW Fortschr Med; 2008 Jun; 150(24):30-2. PubMed ID: 18605057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.